Experience
AbbVie Inc.
Hospira, Inc.
Represented Abbott Laboratories, AbbVie Inc., and Wisconsin Alumni Research Foundation in multiple Hatch-Waxman patent infringement litigations relating to chronic kidney disease drug Zemplar®.
AbbVie Inc. v. Hospira, Inc., 1:11-cv-00648, D. Del., Judge Sleet
AbbVie Inc.
AbbVie Inc. v. Roxane Laboratories Inc.
AbbVie Inc.
AbbVie Inc.
HTC Corp.
AbbVie Inc.
Novartis Vaccines & Diagnostics, Inc. v. MedImmune, LLC
MedImmune, LLC
AbbVie Inc. et al v. Alvotech hf.
AbbVie Inc. et al
Advanced Micro Devices, Inc. v. S3 Graphics Co., Ltd.
S3 Graphics Co., Ltd.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.